Loading...

Eledon Pharmaceuticals, Inc.

ELDN•NASDAQ
Healthcare
Biotechnology
$3.30
$0.10(3.12%)
U.S. Market opens in 16h 41m

Eledon Pharmaceuticals, Inc. (ELDN) Stock Overview

Explore Eledon Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap197.8M
P/E Ratio-5.23
EPS (TTM)$-0.52
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 Month$3.25
3 Months$0.75
1 Year Target$1.06

ELDN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eledon Pharmaceuticals, Inc. (ELDN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.23 and a market capitalization of 197.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.13%
5-Day Change
6.45%
1-Month Change
22.68%
3-Month Change
59.42%
6-Month Change
20.44%
Year-to-Date (YTD) Change
118.54%
1-Year Change
9.63%
3-Year Change
33.06%
5-Year Change
-70.85%
All-Time (Max) Change
-99.91%

Contact Information

https://eledon.com
949 238 8090
19900 MacArthur Boulevard, Irvine, CA, 92612

Company Facts

31 Employees
IPO DateSep 17, 2014
CountryUS
Actively Trading

Frequently Asked Questions